News & Updates
Filter by Specialty:
SGLT2 inhibitors reduce HCC risk in T2DM patients with CHB
The use of sodium-glucose cotransporter 2 (SGLT2) inhibitors is associated with a reduced risk of incident hepatocellular carcinoma (HCC) in patients with coexisting type 2 diabetes mellitus (T2DM) and chronic hepatitis B (CHB), a territory-wide cohort study in Hong Kong has shown.
SGLT2 inhibitors reduce HCC risk in T2DM patients with CHB
18 May 2023
Large for gestational age tied to higher cardiometabolic risks
Individuals born large for gestational age (LGA) are more likely to develop obesity and metabolic syndrome later in life than those born appropriate for gestational age, suggests a study.
Large for gestational age tied to higher cardiometabolic risks
17 May 2023
Weight gain persists, obesity rises in children after pandemic lockdown
Some children, particularly boys, continue to gain weight even after COVID-19 pandemic lockdown measures have been eased, indicating the challenges in reversing the effects of lockdowns, reveals a study in Argentina. However, sedentary behaviours have decreased while quality of life has improved.
Weight gain persists, obesity rises in children after pandemic lockdown
12 May 2023
Low skeletal muscle mass with abdominal obesity ups diabetes risk
Low skeletal muscle mass accompanied by abdominal obesity is significantly associated with a higher risk of incident type 2 diabetes (T2D), irrespective of the glycometabolic parameters, reveals a study.
Low skeletal muscle mass with abdominal obesity ups diabetes risk
08 May 2023
Longer time spent in any physical activity tied to lower T2DM risk
The longer the duration individuals engage in any type of physical activity intensity, the lower their risk of developing type 2 diabetes mellitus (T2DM), regardless of age, sex, body mass index (BMI), or sedentary time, according to a recent study.